Scotiabank analyst Nicholas Yulico lowered the firm’s price target on Healthpeak to $20 from $22 and keeps a Sector Perform rating on the shares. The analyst updated estimates today to reflect recent leasing activity and adjustments to the firm’s future re-leasing assumptions at Healthpeak’s Oyster Point redevelopment campus.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on PEAK: